Emerging multiply resistant enterococci among clinical isolates II. Validation of the Etest to recognize glycopeptide-resistant strains
- 28 February 1995
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 21 (2) , 95-100
- https://doi.org/10.1016/0732-8893(94)00146-n
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United StatesDiagnostic Microbiology and Infectious Disease, 1995
- Genetics and mechanisms of glycopeptide resistance in enterococciAntimicrobial Agents and Chemotherapy, 1993
- Increasing problems in the therapy of enterococcal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- In Vivo Development of Teicoplanin Resistance in a VanB Enterococcus faecium IsolateThe Journal of Infectious Diseases, 1993
- Controversies and confusion regarding antimicrobial susceptibility testing of enterococciAntimicrobic Newsletter, 1992
- Beta-lactamase-producing enterococciAntimicrobial Agents and Chemotherapy, 1992
- Vancomycin resistance gene vanC is specific to Enterococcus gallinarumAntimicrobial Agents and Chemotherapy, 1992
- Ampicillin-resistant enterococcal species in an acute-care hospitalAntimicrobial Agents and Chemotherapy, 1990
- Resistance to vancomycin and teicoplanin: an emerging clinical problemClinical Microbiology Reviews, 1990
- The life and times of the EnterococcusClinical Microbiology Reviews, 1990